The FDA creates an advisory list for dietary supplements; researchers in Israel bio-printed a small-scale heart with human tissue and blood vessels; patient advocates lobby to lift a ban on a controversial fertility treatment.
The FDA is launching a Dietary Supplement Ingredient Advisory List to alert the public when ingredients that appear to be unlawfully marketed are contained in dietary supplements. The FDA said inclusion on the list may not necessarily indicate safety concerns; it may be for reasons including situations in which the ingredient does not fit the definition of a dietary ingredient or the ingredient requires a premarket notification that was not submitted.Researchers in Israel created a small scale, 3-D printed heart with human tissue and blood vessels in an effort to pave the way for the future possibility of producing human organs for transplant, according to Medical Xpress. The printed hearts would need to be trained to behave like real ones. They currently have the ability to contract but lack the ability to pump. Researchers hope to test them in about a year by transplanting them into animals.A group of patient advocates, bioethicists, and scientists are lobbying to have a ban lifted on mitochondrial replacement therapy, a controversial fertility treatment that combines genetic material from an intended father and mother as well as a female donor, reported STAT News. While a Greek woman gave birth to a healthy baby with 3 biological parents last week, the United States banned the procedure in a 2015 congressional amendment. The ban has been renewed annually but supporters say that the procedure could help women who are carriers of genetic diseases have healthy, biologically related children.
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Lack of Mutations Associated With Favorable Prognosis in MPN-U
April 25th 2024While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for myeloproliferative neoplasm, unclassifiable (MPN-U).
Read More
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More